Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067884 · ClinicalTrials.gov registry record · Phase 1
Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery
A Phase 1 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT02067884 is a Phase 1 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 34 participants.
The verdict
NCT02067884, a Phase 1 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
This pilot clinical trial studies contrast enhanced ultrasound and shear wave elastography in measuring response in patients with breast cancer receiving chemotherapy before surgery. New imaging procedures, such as contrast enhanced ultrasound and shear wave elastography, may predict treatment response earlier and more accurately than contrast enhanced magnetic resonance imaging.
Interventions
- DEVICE Philips Shear Wave Elastography
- PROCEDURE dynamic contrast-enhanced ultrasound imaging
- PROCEDURE shear wave elastography
- DRUG Definity, (Lipid Microspheres) Intravenous Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2013-12-19 |
| Est. Completion | 2016-09-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02067884
The ClinicalTrials.gov registry entry for NCT02067884 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Philips Shear Wave Elastography is the first listed.
NCT02067884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02067884 about?
NCT02067884 is a clinical study titled "Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery". This pilot clinical trial studies contrast enhanced ultrasound and shear wave elastography in measuring response in patients with breast cancer receiving chemotherapy before surgery. New imaging procedures, such as contrast enhanced ultrasound and shear wave elastography, may predict treatment respo...
What is the current status of trial NCT02067884?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2013-12-19. Estimated completion is 2016-09-25.
What interventions are being tested in trial NCT02067884?
The interventions under investigation include: Philips Shear Wave Elastography (DEVICE), dynamic contrast-enhanced ultrasound imaging (PROCEDURE), shear wave elastography (PROCEDURE), Definity, (Lipid Microspheres) Intravenous Suspension (DRUG).
Who is sponsoring clinical trial NCT02067884?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.